HEAD OF RARE DISEASE
Avg Cost/Share
$60.45
Shares
4,000
Total Value
$241,800.00
Owned After
107,317
SEC Form 4
HEAD OF RARE DISEASE
Avg Cost/Share
$57.70
Shares
6,500
Total Value
$375,050.00
Owned After
107,317
SEC Form 4
HEAD OF RARE DISEASE
Avg Cost/Share
$61.61
Shares
2,000
Total Value
$123,220.00
Owned After
107,317
SEC Form 4
HEAD OF RARE DISEASE
Avg Cost/Share
$66.00
Shares
5,000
Total Value
$330,000.00
Owned After
107,317
SEC Form 4
HEAD OF RARE DISEASE
Avg Cost/Share
$52.47
Shares
3,000
Total Value
$157,410.00
Owned After
107,317
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Mutz Christopher | ANIP | HEAD OF RARE DISEASE | May 14, 2025 | Sell | $60.45 | 4,000 | $241,800.00 | 107,317 | |
| Mutz Christopher | ANIP | HEAD OF RARE DISEASE | Nov 15, 2024 | Sell | $57.70 | 6,500 | $375,050.00 | 107,317 | |
| Mutz Christopher | ANIP | HEAD OF RARE DISEASE | May 21, 2024 | Sell | $61.61 | 2,000 | $123,220.00 | 107,317 | |
| Mutz Christopher | ANIP | HEAD OF RARE DISEASE | Mar 5, 2024 | Sell | $66.00 | 5,000 | $330,000.00 | 107,317 | |
| Mutz Christopher | ANIP | HEAD OF RARE DISEASE | Nov 10, 2023 | Sell | $52.47 | 3,000 | $157,410.00 | 107,317 |